Vaccine

Vaccine · ISSN (e) 1873-2518 · 6 papers in corpus
2026
doi:10.1016/j.vaccine.2026.128226 ·PMID:41554246

PurposeChanges in menstrual cycle characteristics following COVID-19 vaccination have been reported in women and adolescent girls, yet the biological mechanisms underlying these changes remain poorly understood. Inflammation, though frequen…

2022
doi:10.1016/j.vaccine.2022.04.031 ·PMID:35489985

BackgroundPregnant persons are at increased risk of severe illness from COVID-19 infection, including intensive care unit admission, mechanical ventilation, and death compared with non-pregnant persons of reproductive age. Limited data are …

2021
doi:10.1016/j.vaccine.2021.11.038 ·PMID:34823911
review 2021
doi:10.1016/j.vaccine.2021.07.020 ·PMID:34301432

Bacille Calmette-Guérin (BCG), a vaccine intended to protect against tuberculosis disease, can elicit protection against heterologous infections, and even specific types of cancer. In this mini-review, we will address the possible use of BC…

2015
doi:10.1016/j.vaccine.2015.07.015 ·PMID:26192351

Gonorrhea, one of the most common sexually transmitted infections worldwide, can lead to serious sequelae, including infertility and increased HIV transmission. Recently, untreatable, multidrug-resistant Neisseria gonorrhoeae strains have b…

2008
doi:10.1016/j.vaccine.2008.06.002 ·PMID:18847557

This review focuses on recent publications of clinical trials of two prophylactic human papillomavirus (HPV) vaccines: Gardasil (Merck & Co., Inc., Whitehouse Station, NJ USA), a quadrivalent vaccine containing L1 virus-like particles (VLPs…